NCT01958814View on ClinicalTrials.gov

Beta Agonist Nebulization in Non Invasively Ventilated COPD Patients: Safety, and Therapeutic Efficacy Range.

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Chronic Respiratory Failure
Interventions
DRUG

Salbutamol

First administration of salbutamol or placebo at M0 and 2nd salbutamol or placebo at M60 (or M0 + 60 minutes)

DRUG

Placebo

First administration of salbutamol or placebo at M0 and 2nd salbutamol or placebo at M60 (or M0 + 60 minutes)

Trial Locations (3)

37000

CHRU de Tours, Tours

45000

Service de Réanimation Médicale - CHR d'Orléans, Orléans

86000

Service de Réanimation, Poitiers

All Listed Sponsors
lead

University Hospital, Tours

OTHER

NCT01958814 - Beta Agonist Nebulization in Non Invasively Ventilated COPD Patients: Safety, and Therapeutic Efficacy Range. | Biotech Hunter | Biotech Hunter